Zai Lab Limited (ADR)
General ticker "ZLAB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.4B (TTM average)
Zai Lab Limited (ADR) does not follow the US Stock Market performance with the rate: -16.2%.
Estimated limits based on current volatility of 4.1%: low 17.73$, high 19.25$
Factors to consider:
- Total employees count: 1869 (-14.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Geopolitical risks, Market acceptance, Operational and conduct risks, Third-party risks, Cybersecurity threats
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.01$, 24.27$]
- 2026-12-31 to 2027-12-31 estimated range: [8.65$, 20.70$]
Financial Metrics affecting the ZLAB estimates:
- Negative: with PPE of -11.0 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.75 <= 0.01
- Positive: 42.68 < Shareholder equity ratio, % of 61.03 <= 64.29
- Positive: Investing cash flow per share per price, % of 15.82 > -0.63
- Positive: Inventory ratio change, % of 0.26 <= 0.80
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
Short-term ZLAB quotes
Long-term ZLAB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $276.72MM | $398.99MM | $460.16MM |
| Operating Expenses | $643.29MM | $681.11MM | $689.59MM |
| Operating Income | $-366.57MM | $-282.12MM | $-229.43MM |
| Non-Operating Income | $31.95MM | $25.01MM | $50.97MM |
| Interest Expense | $0.00MM | $2.25MM | $5.21MM |
| R&D Expense | $265.87MM | $234.50MM | $220.90MM |
| Income(Loss) | $-334.62MM | $-257.10MM | $-178.46MM |
| Taxes | $0.00MM | $0.00MM | $-2.93MM |
| Profit(Loss)* | $-334.62MM | $-257.10MM | $-175.54MM |
| Stockholders Equity | $796.12MM | $840.90MM | $715.50MM |
| Inventory | $44.83MM | $39.88MM | $74.75MM |
| Assets | $1,036.30MM | $1,185.75MM | $1,172.38MM |
| Operating Cash Flow | $-198.18MM | $-214.87MM | $-150.79MM |
| Capital expenditure | $8.49MM | $61.52MM | $8.10MM |
| Investing Cash Flow | $-10.78MM | $-375.19MM | $307.87MM |
| Financing Cash Flow | $-6.43MM | $349.89MM | $72.35MM |
| Earnings Per Share** | $-34.63 | $-2.60 | $-1.60 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.